Arbutus Biopharma ABUS reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Arbutus Biopharma beat estimated earnings by 31.25%, reporting an EPS of $-0.11 versus an estimate of $-0.16.
Revenue was up $10.47 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 4.75% drop in the share price the next day.
Here's a look at Arbutus Biopharma's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for Arbutus Biopharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.